Peter M. Rothwell

1.4k total citations · 1 hit paper
10 papers, 927 citations indexed

About

Peter M. Rothwell is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pharmacology. According to data from OpenAlex, Peter M. Rothwell has authored 10 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 3 papers in Surgery and 3 papers in Pharmacology. Recurrent topics in Peter M. Rothwell's work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Inflammatory mediators and NSAID effects (3 papers) and Acute Ischemic Stroke Management (2 papers). Peter M. Rothwell is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Inflammatory mediators and NSAID effects (3 papers) and Acute Ischemic Stroke Management (2 papers). Peter M. Rothwell collaborates with scholars based in United Kingdom, United States and France. Peter M. Rothwell's co-authors include Enrico Floßmann, Marc Fisher, Michael G. Hennerici, Ángel Chamorro, Pierre Amarenco, Ian Ford, Heinrich P. Mattle, Marie‐Germaine Bousser, Kim Fox and Marie-Dominique Fratacci and has published in prestigious journals such as The Lancet, Stroke and Thrombosis and Haemostasis.

In The Last Decade

Peter M. Rothwell

9 papers receiving 901 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies

2007 620 citations Enrico Floßmann, Peter M. Rothwell The Lancet profile →

Peers

Countries citing papers authored by Peter M. Rothwell

Since Specialization

Citations

This map shows the geographic impact of Peter M. Rothwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Rothwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Rothwell more than expected).

Fields of papers citing papers by Peter M. Rothwell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Rothwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Rothwell. The network helps show where Peter M. Rothwell may publish in the future.

Co-authorship network of co-authors of Peter M. Rothwell

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. Rothwell. A scholar is included among the top collaborators of Peter M. Rothwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. Rothwell. Peter M. Rothwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Current practice in ultrasound grading of carotid artery stenosis in the UK and Ireland 2024 ·(unknown), (unknown), (unknown), (unknown), (unknown), D. Howard, Rachel Potter, Peter M. Rothwell, (unknown), (unknown)	2
2	Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview 2020 ·UNC Libraries ·Nadir Arber, P C Elwood, John Burn, Peter M. Rothwell, Andrew T. Chan, Whay Kuang Chia, Karsten Schrör, Mark A. Hull, John A. Baron, R. F. L. Logan	0
3	ecancermedicalscience 2016 ·ecancermedicalscience ·Gareth J. Morgan, Peter M. Rothwell, John Burn, Andrew T. Chan, Luis A. J. Mur, Dion Morton, Jack Cuzick, Gordon McVie, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
4	Paracetamol, Ibuprofen, and Recurrent Major Cardiovascular and Major Bleeding Events in 19 120 Patients With Recent Ischemic Stroke 2016 ·Stroke ·Jaime Gonzalez-Valcarcel, Leïla Sissani, Julien Labreuche, Marie‐Germaine Bousser, Ángel Chamorro, Marc Fisher, Ian Ford, Kim Fox, Michael G. Hennerici, Heinrich P. Mattle, Peter M. Rothwell, Philippe Gabríel Steg, Éric Vicaut, Pierre Amarenco, (unknown)	7
5	Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients 2014 ·Stroke ·Gaia Sirimarco, Julien Labreuche, Éric Bruckert, Larry B. Goldstein, Kim Fox, Peter M. Rothwell, Pierre Amarenco, Marie‐Germaine Bousser, Ángel Chamorro, Ian Ford, Marc Fisher, Michael G. Hennerici, Heinrich P. Mattle, (unknown), Henrik Sillesen, K.M.A. Welch, Justin A. Zivin	85
6	Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial 2011 ·The Lancet ·Marie‐Germaine Bousser, Pierre Amarenco, Ángel Chamorro, Marc Fisher, Ian Ford, Kim Fox, Michael G. Hennerici, Heinrich P. Mattle, Peter M. Rothwell, Agnès de Cordoüe, Marie-Dominique Fratacci	143
7	The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients with a History of Ischemic Stroke or Transient Ischemic Attack (PERFORM) Study: Baseline Characteristics of the Population 2009 ·Cerebrovascular Diseases ·Marie‐Germaine Bousser, Pierre Amarenco, Ángel Chamorro, Marc Fisher, Ian Ford, Keith A.A. Fox, Michael G. Hennerici, Heinrich P. Mattle, Peter M. Rothwell	28
8	What is the Optimum Model of Service Delivery for Transient Ischaemic Attack?: Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R&D (NCCSDO) 2008 ·Jonathan Mant, Ronan Ryan, Richard J. McManus, Kate Fletcher, Rebecca Kandiyali, Pelham Barton, Gary A. Ford, Stirling Bryan, Andrew Stevens, Peter M. Rothwell	5
9	Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease 2008 ·Thrombosis and Haemostasis ·Shirley Williams, Diane J. Nugent, Paul Harrison, Helen Segal, (unknown), Peter M. Rothwell, Thomas J. Kunicki	36
10	Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies breakdown → 2007 ·The Lancet ·Enrico Floßmann, Peter M. Rothwell	620

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact